Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo
Tajeddine, Nicolas, Louis, Magali, Vermylen, Christiane, Gala, Jean-Luc, Tombal, Bertrand, Gailly, PhilippeVolume:
49
Langue:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190802035933
Date:
January, 2008
Fichier:
PDF, 253 KB
english, 2008